Full year Financial Information at March 31, 2018
IFRS - Regulated Information - Not Audited
Cegedim: revenue growth continues
| Disclaimer: This press release is available in French and in English. In the event of any difference between the two versions, the original French version takes precedence. This press release may contain inside information. It was sent to Cegedim's authorized distributor on April 26, 2017, no earlier than 5:45 pm Paris time.|
The terms "business model transformation" and "BPO" are defined in the glossary.
Owing to the disposal of the Group's Cegelease and Eurofarmat businesses, announced in 2017 and completed on February 28, 2018, the consolidated 2017 and 2018 financial statements are presented according to IFRS 5, "Non-current assets held for sale and discontinued". See the annexes for more details.
The Group also applies the IFRS 15 accounting standard, "Revenue from contracts with customers".
| Conference CALL on APRIL 26, 2018, at 6:15PM CET |
| FR: +33 1 70 71 01 59 || USA: +1 646 722 4916 || UK: +44 207 1943 759 || PIN Code: 15730811# |
| The webcast is available at the following address: www.cegedim.fr/webcast |
Boulogne-Billancourt, France, April 26, 2018, after the market close
Cegedim, an innovative technology and services company, posted consolidated Q1 2018 revenues from continuing activities of €111.9 million, up 1.8% on a reported basis and 2.6% like for like compared with the same period in 2017.
The application of the new IFRS 15 accounting standard has no material impact on Group revenue.
Cegedim's business model transformation is progressing according to plan. As a result, the Insurance, HR and e-services division continued to post robust growth in the first quarter of 2018, while Healthcare professionals division revenues fell ahead of new product launches in the UK and US.
As a reminder, the Group's first-quarter and third-quarter revenue figures are typically slightly lower than what it generates in the second quarter and especially the fourth quarter.
Revenue trends by division
| || || First quarter |
| In € million || || 2018 || 2017 || Chg. L-f-l || Chg. Reported |
| Health insurance, HR and e-services || || 72.9 || 68.6 || +6.4% || +6.3% |
| Healthcare professionals || || 38.0 || 40.3 || (3.5)% || (5.7)% |
| Corporate and others || || 1.0 || 1.1 || (6.5)% || (6.5)% |
| Cegedim || || 111.9 || 110.0 || +2.6% || +1.8% |
In the first quarter of 2018, Cegedim posted consolidated revenues from continuing activities of €111.9 million, up 1.8% on a reported basis. Excluding an unfavorable currency translation effect of 0.8%, revenues rose 2.6%. There was virtually no impact from acquisitions or disposals in this quarter.
The unfavorable currency translation effect of €0.9 million, or 0.8%, was chiefly due to the €0.5 million negative impact of the US dollar, which represents 2.6% of Group revenues, and the €0.3 million negative impact of the pound sterling, which represents 9.8% of revenues.
In like-for-like terms, Health insurance, HR and e-services division revenues rose by 6.4%, and Healthcare professionals division revenues declined by 3.5%.
Analysis of business trends by division
The division's Q1 2018 revenues came to €72.9 million, up 6.3% on a reported basis. Currency translation had a negative impact of 0.1%. There were no acquisitions or divestments. Like-for-like revenues rose 6.4% over the period.
The Health insurance, HR and e-services division represented 65.1% of consolidated revenues, compared with 62.4% over the same period a year earlier.
The businesses that made the biggest contributions to growth were Cegedim SRH (HR management solutions), Cegedim e-business (digitalization and data exchange), sales statistics for pharmaceutical products, and the computerization of health insurance companies in the UK. This performance was partially offset by the impact of switching the health insurance company computerization activity over to a SaaS model in France, and by the timing of C-MEDIA campaigns (ad space in pharmacies and health & wellness shops).
The division's Q1 2018 revenues came to €38.0 million, down 5.7% on a reported basis. Currency translation had a negative impact of 2.1%. There was virtually no impact from acquisitions or divestments. Like-for-like revenues fell 3.5% over the period.
The Healthcare professionals division represented 34.0% of consolidated revenues from continuing activities, compared with 36.7% over the same period a year earlier.
The division was negatively affected by doctor computerization activities in the UK, the US and Spain ahead of new product launches. This impact was partly offset by computerization activities for doctors and allied health professionals in France. The stability of the pharmacy computerization business in France is particularly noteworthy.
The division's Q1 2018 revenues came to €1.0 million, down 6.5% on a reported basis and like for like. There was no currency impact and no acquisitions or divestments.
The Corporate and others division represented 0.9% of consolidated revenues from continuing activities compared with 1.0% over the same period a year earlier
Apart from the items cited below, to the best of the company's knowledge, there were no events or changes during the period that would materially alter the Group's financial situation.
Bpifrance Participations sold 1,682,146 Cegedim shares via an accelerated bookbuilding process to French and international institutional investors at a price of €35 per share on February 13, 2018. In the context of the transaction, the shareholders' agreement dated October 28, 2009, between Mr. Jean-Claude Labrune, FCB (the family holding company controlled by Mr. Labrune), and Bpifrance - as well as the concert between the parties - has been terminated. Following the sale, Cegedim's free float increased to 44% of capital (vs. 32% before the transaction).
On February 28, 2018, Cegedim announced that it had completed the disposal of Cegelease and Eurofarmat to FRANFINANCE of the Société Générale Group for an amount of €57.5 million plus reimbursement of the shareholder's loan account, which amounted to €13 million. Of this amount, Cegedim used €30 million to pay down its debt.
The parties have decided that Cegelease and the Cegedim Group will continue to collaborate in France under their current terms as part of a six-year collaboration agreement.
On March 30, 2018, Cegedim acquired French company Rue de la Paye via its Cegedim SRH subsidiary. The deal will enable the Group to market digital payroll solutions to 2 million SMEs and small businesses in France, including - importantly - thousands of healthcare professionals that are already Cegedim Group clients.
Rue de la Paye's 2017 revenues were equivalent to around 1% of Group 2017 revenues, and it earned a profit. It began contributing to the Group's consolidation scope in April 2018.
On February 21, 2018, Cegedim S.A. received notice that French tax authorities would perform an audit of its accounts covering the period January 1, 2015, to December 31, 2016.
Significant post-closing transactions and events
To the best of the company's knowledge, there were no events or changes after the accounts were closed that would materially alter the Group's financial situation.
Building on the efforts that it executed with success in 2017, Cegedim continues to pursue its strategy of focusing on organic growth, fueled by a policy of sustained innovation.
For 2018 the Group targets a moderate organic revenue and EBITDA margin growth. The Group does not issuing any earnings estimates or forecasts.
In 2017, the UK accounted for 10.9% of consolidated Group revenues from continuing activities and 14.0% of consolidated Group EBIT.
Cegedim deals in local currency in the UK, as it does in every country where it is present. Thus, Brexit is unlikely to have a material impact on Group EBIT.
With regard to healthcare policy, the Group has not identified any major European programs at work in the UK and expects UK policy to be only marginally affected by Brexit.
The figures cited above include guidance on Cegedim's future financial performances. This forward-looking information is based on the opinions and assumptions of the Group's senior management at the time this press release is issued and naturally entails risks and uncertainty. For more information on the risks facing Cegedim, please refer to Chapter 2 points 4.2, "Risk factors and insurance", and 5.5, "Outlook", of the 2017 Registration Document filed with the AMF on March 29, 2018, under number D.18-0219.
Revenue figures for Q1 2018 have not been audited by the Statutory Auditors.
| || June 19, 2018, at 9:30 am CET |
July 26, 2018, after the market close
| Cegedim shareholders' meeting|
Second-quarter 2018 revenues
Financial calendar, H1 2018
| April 26, 2018, at 6:15pm (Paris time) |
| The Group will hold a conference call hosted by Jan Eryk Umiastowski, Cegedim Chief Investment Officer and Head of Investor Relations.|
The webcast is available at the following address: www.cegedim.fr/webcast
The presentation on Q1 2018 revenues is available on the website and on the Group's financial communications app, Cegedim IR.
| Contact Numbers : || France: +33 1 70 71 01 59|
United States: +1 646 722 4916
UK and others: +44 207 1943 759
| PIN Code: 15730811# |
Breakdown of revenues from continuing activities by quarter and division
| In € thousands || || Q1 || Q2 || Q3 || Q4 || Total |
| Health insurance, HR and e-services || || 72,923 || || || || || |
| Healthcare professionals || || 38,029 || || || || || |
| Corporate and others || || 989 || || || || || |
| Cegedim || || 111,941 || || || || || |
| In € thousands || || Q1 || Q2 || Q3 || Q4 || Total |
| Health insurance, HR and e-services || || 68,610 || 71,653 || 67,958 || 82,856 || 291,077 || |
| Healthcare professionals || || 40,320 || 41,495 || 37,999 || 42,672 || 162,486 || |
| Corporate and others || || 1,058 || 933 || 961 || 926 || 3,878 || |
| Cegedim || || 109,989 || 114,081 || 106,918 || 126,454 || 457,441 || |
Breakdown of revenues from continuing activities by geographic zone and division
| In € thousands || || France || EMEA excl. France || Americas || APAC |
| Health insurance, HR and e-services || || 97.0% || 3.0% || - || - |
| Healthcare professionals || || 62.2% || 29.9% || 7.9% || - |
| Corporate and others || || 100.0% || - || - || - |
| Cegedim || || 85.2% || 12.1% || 2.7% || - |
Breakdown of revenues from continuing activities by currency and division
| In € thousands || || Euro || GBP || USD || Others |
| Health insurance, HR and e-services || || 97.0% || 2.1% || - || 1.0% |
| Healthcare professionals || || 65.9% || 25.0% || 7.6% || 1.5% |
| Corporate and others || || 100.0% || - || - || - |
| Cegedim || || 86.4% || 9.8% || 2.6% || 1.2% |
Application of IFRS 5
On December 14, 2017, Cegedim announced that it had signed a contract for the definitive sale of its Cegelease and Eurofarmat businesses. The deal was finalized on February 28, 2018. As a result, the consolidated 2017 and Q1 2018 financial statements are presented according to IFRS 5, "Non-current assets held for sale and discontinued". IFRS 5 governs the accounting treatment for non-current assets held for sale.
In practice, their contribution to each line of Cegedim's consolidated income statement (before minority interests) is combined into the "Net profit from activities sold or held for sale" line, and the group share of their net profit is excluded from Cegedim's adjusted net profit. Earlier periods have also been restated so that the information presented is comparable.
The table below shows the impact of the restatement:
| in € thousands || || Q1 2018 || Q1 2017 || Change |
| Revenue from continuing activities || || 111,941 || 109,989 || +1.8% |
| Revenue from assets held for sale || || 2,211 || 3,926 || (43.7)% |
| IFRS 5 restatement || || (182) || (209) || (13.2)% |
| Group revenues || || 113,970 || 113,705 || +0.2% |
| BPO (Business Process Outsourcing): BPO is the contracting of non-core business activities and functions to a third-party provider. Cegedim provides BPO services for human resources, Revenue Cycle Management in the US and management services for insurance companies, provident institutions and mutual insurers.|
Business model transformation: Cegedim decided in fall 2015 to switch all of its offerings over to SaaS format, to develop a complete BPO offering, and to materially increase its R&D efforts. This is reflected in the Group's revamped business model. The change has altered the Group's revenue recognition and negatively affected short-term profitability
Corporate and others: This division encompasses the activities the Group performs as the parent company of a listed entity, as well as the support it provides to the three operating divisions.
EPS: Earnings Per Share is a specific financial indicator defined by the Group as the net profit (loss) for the period divided by the weighted average of the number of shares in circulation.
Operating expenses: Operating expenses is defined as purchases used, external expenses and payroll costs.
Revenue at constant exchange rate: When changes in revenue at constant exchange rate are referred to, it means that the impact of exchange rate fluctuations has been excluded. The term "at constant exchange rate" covers the fluctuation resulting from applying the exchange rates for the preceding period to the current fiscal year, all other factors remaining equal.
Revenue on a like-for-like basis: The effect of changes in scope is corrected by restating the sales for the previous period as follows:
Life-for-like data (L-f-l): At constant scope and exchange rates.
by removing the portion of sales originating in the entity or the rights acquired for a period identical to the period during which they were held to the current period;
similarly, when an entity is transferred, the sales for the portion in question in the previous period are eliminated.
Internal growth: Internal growth covers growth resulting from the development of an existing contract, particularly due to an increase in rates and/or the volumes distributed or processed, new contracts, acquisitions of assets allocated to a contract or a specific project.
| || External growth: External growth covers acquisitions during the current fiscal year, as well as those which have had a partial impact on the previous fiscal year, net of sales of entities and/or assets.|
EBIT: Earnings Before Interest and Taxes. EBIT corresponds to net revenue minus operating expenses (such as salaries, social charges, materials, energy, research, services, external services, advertising, etc.). It is the operating income for the Cegedim Group.
EBIT before special items: This is EBIT restated to take account of non-current items, such as losses on tangible and intangible assets, restructuring, etc. It corresponds to the operating income from recurring operations for the Cegedim Group.
EBITDA: Earnings before interest, taxes, depreciation and amortization. EBITDA is the term used when amortization or depreciation and revaluations are not taken into account. "D" stands for depreciation of tangible assets (such as buildings, machines or vehicles), while "A" stands for amortization of intangible assets (such as patents, licenses and goodwill). EBITDA is restated to take account of non-current items, such as losses on tangible and intangible assets, restructuring, etc. It corresponds to the gross operating earnings from recurring operations for the Cegedim Group.
Adjusted EBITDA : Consolidated EBITDA adjusted, for 2016, for the €4.0m of negative impact from impairment of receivables in the Healthcare Professional division
Net Financial Debt: This represents the Company's net debt (non-current and current financial debt, bank loans, debt restated at amortized cost and interest on loans) net of cash and cash equivalents and excluding revaluation of debt derivatives.
Free cash flow: Free cash flow is cash generated, net of the cash part of the following items: (i) changes in working capital requirements, (ii) transactions on equity (changes in capital, dividends paid and received), (iii) capital expenditure net of transfers, (iv) net financial interest paid and (v) taxes paid.
EBIT margin: EBIT margin is defined as the ratio of EBIT/revenue.
EBIT margin before special items: EBIT margin before special items is defined as the ratio of EBIT before special items/revenue.
Net cash: Net cash is defined as cash and cash equivalent minus overdraft.
| About Cegedim:|
Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs more than 4,200 people in more than 10 countries and generated revenue of €457 million in 2017. Cegedim SA is listed in Paris (EURONEXT: CGM).
To learn more, please visit: www.cegedim.com
And follow Cegedim on Twitter: @CegedimGroup, LinkedIn and Facebook.
and Communications Manager
Tel.: +33 (0)1 49 09 68 81
Jan Eryk Umiastowski
Chief Investment Officer
and head of Investor Relations
Tel.: +33 (0)1 49 09 33 36
For Madis Phileo
Tel: +33 (0)6 71 58 00 34
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cegedim SA via Globenewswire